Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (10)
P 1 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed7
Not Yet Recruiting6
Recruiting6
Active Not Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06613438Not ApplicableRecruitingPrimary

Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms

NCT07125521Not ApplicableRecruitingPrimary

Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare

NCT07308041Phase 1Completed

A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin

NCT07364838Phase 1CompletedPrimary

Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

NCT07313774Phase 3Not Yet RecruitingPrimary

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

NCT07252180Not ApplicableActive Not RecruitingPrimary

Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA)

NCT07252115Not ApplicableRecruiting

TLSA Versus TBSA Surgical Approach for Hiatal Hernia With Gastroesophageal Reflux Disease

NCT07178821Not ApplicableNot Yet Recruiting

Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD

NCT07037875Phase 3Not Yet RecruitingPrimary

A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

NCT07127276Not ApplicableNot Yet RecruitingPrimary

Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare

NCT07121803Not ApplicableRecruiting

The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility

NCT07022912Not Yet Recruiting

PPI Refractory - GERD Mechanisms in Systemic Sclerosis

NCT06928350RecruitingPrimary

Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants

NCT07004400Not ApplicableNot Yet RecruitingPrimary

A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD

NCT06986902Not ApplicableCompletedPrimary

Comparative Analysis of Postoperative Manometry Outcomes in Nissen vs Toupet Fundoplication

NCT06973070CompletedPrimary

Upper GI MM vs Manometry

NCT06495606RecruitingPrimary

"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?

NCT06151067CompletedPrimary

Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease

NCT03270722Not ApplicableWithdrawn

Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

NCT02505945Phase 4CompletedPrimary

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

Scroll to load more

Research Network

Activity Timeline